Toyota Global Sales Fall as China Demand Slumps 
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation 
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
OpenAI AI Agent Swarm Behind Hugging Face Hack 
Amazon Secures 200 MW Wind Power Deals in Sweden 
Google Changes EU Spam Policy Amid Antitrust Scrutiny 
Honda, Nissan Eye Shared Vehicle Software Platform by 2029 
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
Meta Agrees to $18 Billion Settlement, Tightens Teen Social Media Rules 
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question 
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’ 
Itochu Offers $1.56 Billion to Privatize Dentsu Soken 
GM Plans C$1.1 Billion Canada Investment Amid U.S. Tariff Pressure 
Street Poller Media and The Boom of the Street Interview Ad Industry 
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 
Add as a preferred source on Google
NEW YORK, April 09, 2018 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Eastern District of New York on behalf of investors who purchased Henry Schein, Inc. ("Henry Schein") (NASDAQ:HSIC) securities between March 7, 2013 and February 12, 2018.
Click here to learn about the case: http://www.wongesq.com/pslra-c/henry-schein-inc?wire=3. There is no cost or obligation to you.
According to the complaint, throughout the Class Period, the Company issued materially false and misleading statements and/or failed to disclose that: (1) Henry Schein was engaging in unethical, anti-competitive behavior through agreements with Benco Dental Supply Company and Patterson Companies, Inc., in violation of United States antitrust laws; (2) Henry Schein engaged in such behavior, in part, to help maintain profitability in a consolidating health care industry; (3) these violations of U.S. antitrust laws would result in heightened scrutiny by the federal government and a lawsuit filed by the Federal Trade Commission (“FTC”); (4) Henry Schein failed to maintain adequate internal controls; and (5) as a result, defendants' statements about Henry Schein’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
If you suffered a loss in Henry Schein you have until May 7, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra-c/henry-schein-inc?wire=3.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]
